NASDAQ:SGRY
Surgery Partners, Inc.
Surgery Partners, Inc.'s revenue grew 6.2% in fiscal 2025 to $3.3B while operating margin rose to 11.8%. Free cash flow was $195.6M, 5.9% of revenue, and the diluted share count rose 0.9%.Summary generated from Surgery Partners, Inc.'s SEC filings. Latest annual report filed Mar 2, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$3.3B
Revenue growth+6.2%
Revenue, 5-yr CAGR+12.2%
Gross marginn/a
Operating margin11.8%
Net margin−2.4%
ROIC6.1%
Return on equity−4.4%
Debt / equity2.18
Free cash flow$195.6M
FCF margin5.9%
Share count change+0.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2,225 | 2,539 | 2,743 | 3,114 | 3,309 |
| Operating income | 302 | 345 | 328 | 349 | 390 |
| Net income | −71 | −55 | −12 | −168 | −78 |
| Free cash flow | 30 | 78 | 205 | 210 | 196 |
Recent filings
- 8-KCompletion of an acquisition or disposition
Sep 17, 2026 - 4Insider transaction report
Aug 19, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 8-KEntry into a material agreement
Jul 24, 2026 - 4Insider transaction report
Jul 14, 2026 - 8-KResults of a shareholder vote
Jun 5, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 5, 2026